ロード中...
Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19
Hospital admissions and mortality from the Coronavirus disease 2019 (COVID-19) pandemic are spreading throughout the world, and second and third waves are thought to be likely. Risk factors for severe COVID-19 include diabetes, chronic kidney disease and cardiovascular disease. Currently, there is n...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7409231/ https://ncbi.nlm.nih.gov/pubmed/32605278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072030 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|